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Abstract
Background Personality factors and psychiatric history may
help explain individual differences in risk of psychological
morbidity and poor health outcomes in patients with an
implantable cardioverter defibrillator (ICD).
Purpose We examined associations between previous anxi-
ety and depressive disorder, type D personality, anxiety or
depressive symptoms, and health status in ICD patients prior
to ICD implantation.
Method Patients (N0278; 83 % men; mean age062.2 years
±11) receiving a first ICD from September 2007 through
April 2010 at the Medisch Spectrum Twente, The Nether-
lands completed validated questionnaires before implanta-
tion assessing type D personality (14-item Type D Scale),
anxiety and depressive symptoms (Hospital Anxiety and
Depression Scale), and health status (36-item Short Form
Health Survey). History of anxiety or depressive disorder
was assessed with the Mini International Neuropsychiatric
Interview structural interview.
Results Previous anxiety or depressive disorder was preva-
lent in 8 and 19 % of patients, respectively. Type D person-
ality was present in 21 %, depressive symptoms in 15 %,
and anxiety in 24 %. In adjusted analyses, type D person-
ality was a dominant correlate of previous depressive dis-
order (odds ratio (OR) 6.2, p<0.001) and previous anxiety
disorder (OR 3.9, p00.004). Type D personality (OR 4.0, p<
0.001), age (OR 1.03, p00.043), and gender (OR 2.5, p0
0.013) were associated with anxiety symptoms at baseline.
Type D personality (OR 5.9. p<0.001) was also associated
with increased depressive symptoms at baseline. Heart failure
and type D personality were related to poorer health status.
Conclusion In ICD patients, prior to ICD implantation, a
previous anxiety or depressive disorder, type D personality,
and anxiety and depressive symptoms were associated with
poorer health status. Type D personality was also independ-
ently associated with increased anxiety and depression
symptoms.
Keywords Anxiety . Depression . Health status . ICD .
Type D personality
Introduction
Sudden cardiac death (SCD) is a common manifestation of
coronary heart disease (CHD) and is responsible for about
50 % of deaths from cardiovascular disease in developed
countries [1]. Several primary and secondary prevention
trials have demonstrated the efficacy of the implantable
cardioverter defibrillator (ICD) compared to anti-arrhythmic
drugs in reducing the number of SCDs by treating potentially
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life-threatening ventricular arrhythmias [2–4]. ICDs prevent
SCD by converting ventricular arrhythmias into a normal
rhythm by the use of anti-tachycardia pacing or shock therapy.
A subset of ICD patients have difficulty with psychological
functioning following implantation, with 25–33 % of patients
displaying significant symptoms of anxiety, depression, and
posttraumatic stress [5–8]. In turn, preimplantation psycholog-
ical morbidity, such as anxiety, depression, and posttraumatic
stress, have been shown to negatively influence mortality,
morbidity, and health status in ICD patients [7, 9–11].
The manifestation of psychological morbidity may be
attributed to a combination of factors, including the ICD
implantation, the occurrence of ICD shocks, the type of
underlying heart disease and psychological symptoms, such
as anxiety and depression [12, 13]. Preliminary evidence
suggests that personality factors may also help to identify
patients at risk for developing adverse health outcomes in
the future [14–18]. Type D personality, defined as the ten-
dency to experience negative emotions combined with the
tendency to inhibit these emotions in social interactions
[14], seems to constitute a vulnerability factor for future
anxiety, depression [19], and poor health status [16], regard-
less of the underlying cardiac disease pathology. Moreover,
anxious ICD patients with a type D personality have a 70 %
increased risk of ventricular arrhythmias, possibly due to the
modulating effect of personality on emotional distress [20]
and also a higher risk of mortality [21].
Most psychological studies in ICD recipients have
focused on symptoms after implantation, neglecting the role
of a previous history of psychiatric disorders [10, 22, 23]. To
our knowledge, this has only been investigated in one study,
showing that a previous diagnosis of depression predicts
poor health status in ICD patients [18]. This despite findings
demonstrating that a previous history of psychiatric disorder
has a significant impact on the development of heart disease
[24]. After myocardial infarction, a history of anxiety disorder
predicts the occurrence of reduced heart rate variability [25], a
known risk factor for future ventricular arrhythmia.
In ICD patients, it has been shown that distress (as
reflected by increased anxiety and depressive symptoms)
and poor health status at the time of implantation are risk
factors for the onset of ventricular arrhythmias but also for
mortality [10, 20, 21, 26]. Increasing our understanding of
which personality factors are associated with an increased
risk of psychological distress prior to ICD implantation may
help health care professionals to identify patients at risk in
order to optimize their clinical management and care.
The objective of the current cross-sectional study was to
examine the association between type D personality and
a previous anxiety or depressive disorder, and current
health status, but also the association between type D
personality and anxiety- or depressive symptoms prior to
ICD implantation.
Method
Patients and Design
The study population consisted of a consecutive cohort of
patients implanted with an ICD at Medisch Spectrum
Twente (N0278; 83.4 % men; mean age062.2 years ±11),
Enschede, The Netherlands, between September 2007 and
April 2010, as part of the Twente ICD Cohort Study (TICS,
American trial register number NL13939.044.06). The TICS
study was designed to examine the value of biomedical and
psychological risk markers for predicting life-threatening
ventricular arrhythmias requiring ICD therapy. Patients
meeting the following inclusion criteria were eligible for
participation in the study: (1) an indication for a first ICD
implantation according to the guidelines of The Netherlands
Society of Cardiology and the European Society of Cardiol-
ogy [2, 27, 28], (2) age ≥18 years at the time of implantation,
and (3) providing written informed consent. Exclusion criteria
were inability to read or write Dutch, congenital heart disease,
major psychiatric disorders other than affective spectrum dis-
orders (e.g., psychosis, dementia), and participation in other
studies. The included patients completed a set of standardized
and validated questionnaires before ICD implantation,
referred to as baseline in the remainder of the paper. Twenty-
five patients did not return the questionnaires. With a response
rate of 80.1 %, statistical analyses were based on 278 patients
(Fig. 1). The study was conducted according to the Helsinki
Declaration and the research protocol was approved by the
local ethics committee. All patients provided written informed
consent.
Measures
Demographic and Clinical Variables
Information on demographic and clinical variables was col-
lected from the patients’ medical records before implanta-
tion. Clinical variables included indication for ICD
placement (i.e., primary versus secondary prevention), eti-
ology (i.e., ischemic versus non-ischemic), comorbidity
(i.e., chronic obstructive pulmonary disease, hypertension,
or diabetes mellitus), smoking, alcohol use, New York Heart
Association (NYHA) functional class, left ventricular ejec-
tion fraction (LVEF), and medication (i.e., beta blockers,
amiodarone, diuretics, aldosterone antagonist, and ACE
inhibitors).
Psychological Questionnaires
Anxiety and Depressive Symptoms Symptoms of anxiety
and depression were evaluated with the Hospital Anxiety
and Depression Scale (HADS) [29]. The HADS is a
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validated self-report measure consisting of 14 questions that
tap into current symptoms of anxiety and depression. Items
are answered on a four-point Likert scale (0–3), with a score
range of 0–21 for both anxiety and depression. A higher
score indicates more symptoms of anxiety or depression.
The HADS was designed to be used as a screening instru-
ment and not as a case identifier for anxiety or depressive
disorder [30]. Scores on both scales ≥8 are indicative of
elevated anxiety or depressive symptoms [31]. The HADS
has sufficient to good psychometric properties, as indicated
by Cronbach’s α00.71 and α00.90 for the anxiety and
depression subscales, respectively, and test–retest reliability
of 0.86 and 0.91, respectively [30].
History of Depressive or Anxiety Disorder History of anxi-
ety disorder or depressive disorder was measured with the
Dutch version of the Mini International Neuropsychiatric
Interview (MINI) [32, 33]. This is a structured diagnostic
interview that systematically determines psychiatric diagno-
ses. It was developed to meet the need for a short but
accurate structured psychiatric interview for multicenter
clinical trials and epidemiological studies, addressing the
feasibility shortcomings of two other frequently used struc-
tured psychiatric interviews, the Structured Clinical Interview
for DSM-IV-TR Axis I and the Composite International Diag-
nostic Interview. In this study, only the parts relating to
depressive disorder and anxiety disorder were administered.
Test–retest reliability Kappa scores are 0.89 and 0.79, inter-
rater Kappa scores are 1.00 and 0.97, respectively [32].
Type D Personality Type D personality was measured with
the 14-item Type D Scale (DS14) [34], a self-report ques-
tionnaire assessing the personality traits negative affectivity
(seven items; e.g., “I often feel unhappy”) and social inhib-
ition (seven items; e.g., “I am a closed kind of person”).
Items are answered on a five-point Likert scale from 0 (not
true) to 4 (true), with scores ranging from 0 to 28 for both
subscales. Type D caseness is defined by a score of ≥10 on
both subscales [34], with this cutoff shown to be the most
optimal according to item response theory [35]. The DS14
has good psychometric properties with Cronbach’s α00.88/
0.86 and 3-month test–retest reliability00.72/0.82 for the
negative affectivity and the social inhibition subscales,
respectively [34]. Type D personality is not confounded by
indicators of disease severity, such as left ventricular dys-
function, in post myocardial infarction patients [36, 37], nor
by New York Heart Association functional class in patients
with CHF [38].
Total number of patients receiving a first ICD 
Excluded  due to exclusion criteria 
Logistic reasons for exclusion 
Death before informed consent 
Other reasons 
Eligible patients 
Refused participation 
Included in the TICS 
Baseline score on Type D personality questionnaire missing 
Included in statistical analyses N = 278 
N = 480 
N = 64
N = 31 
N = 25 
N = 303 
N = 1
N = 37
N = 44 
N = 347 
Fig. 1 Patient selection for the
current study
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Health Status Health status was assessed with the 36-item
Short Form Health Survey (SF-36) [39]. The SF-36 is a self-
report measure composed of eight multi-item scales: phys-
ical functioning, social functioning, vitality, role limitations
(physical problems), role limitations (emotional problems),
general mental health, bodily pain, and general health per-
ception. The raw scores are transformed into scale scores
ranging from 0 to 100, with a higher score indicative of a
better health status (e.g., the absence of pain for the bodily
pain scale). The SF-36 has good psychometric properties,
with Cronbach’s α ranging from 0.78 to 0.93 for the sepa-
rate subscales in a sample of 4,172 Dutch adults [39].
Statistical Analyses
The chi-square test (Fisher’s exact test when appropriate)
was used to compare nominal variables, whereas Student’s t
test for independent samples or ANOVA (or the Mann–
Whitney U test or the Kruskal–Wallis test, as appropriate)
was used to compare continuous variables between groups.
The relationship between two continuous variables was
assessed with Pearson’s or Spearman’s rho correlation anal-
yses, as appropriate. Multivariate logistic or linear regres-
sion analysis was performed, as appropriate, to investigate
the relationship between type D personality and a history of
anxiety or depressive disorder, anxiety or depressive symp-
toms prior to ICD implantation, and health status domains.
A priori based on the literature on the associates of distress
and health status in ICD patients, we chose to include sex,
age, ICD indication, etiology, NYHA functional class, and
LVEF in adjusted analysis. Given that the comorbidity of
anxiety and depression is high, with a prevalence of 50–
60 % [40], depressive symptoms were not included as a
variable in the analysis of the relationship between type D
personality and anxiety symptoms. Likewise, anxiety symp-
toms were not included as a variable in the analysis of the
relationship between type D personality and depressive
symptoms. Finally, for the same reason, a history of a
depressive or anxiety disorder was not included as a variable
in the analyses of the relationship between type D person-
ality and anxiety and depressive symptoms. Variables were
removed from the models, based on their statistical signifi-
cance, to obtain parsimonious models. In case of multi
colinearity, anticipated based on common sense and verified
by t tests, chi-square tests, and Pearson’s correlation, various
models were compared leaving out successive correlating
variables. Model fit was then compared with either 2-log
likelihood or r-squared, as appropriate. Effect modification
by symptoms of anxiety and depression and a history of
anxiety or depressive disorder in the relationship between
type D personality and health status domains was antici-
pated. Therefore, interaction terms of type D personality and
a history of anxiety or depressive disorder, and symptoms of
anxiety and depression, were added to all final multivariate
models with health status as outcome. If effect modification
was present, stratified analyses by the effect modifier were
performed. A P value of <0.05 was considered statistically
significant. All analyses were performed with SPSS 15.01.
Results
Sample Characteristics
Between September 2007 and April 2010, 480 patients
received an ICD at Medisch Spectrum Twente, Enschede,
The Netherlands. Out of 347 eligible patients, 44 patients
refused to participate. The remaining 303 patients were
included in the TICS study.
Baseline characteristics for the total sample and stratified
by type D personality are shown in Table 1. The prevalence
of Type D personality was 21 %, depressive symptoms
15 %, and anxiety 24 %. A history of anxiety or depressive
disorder was prevalent in 8 and 19 % of patients, respectively.
Patients with a type D personality differed from non-type D
patients on smoking, use of an aldosterone antagonist and use
of a beta-blocker, etiology, age, and LVEF. On all other
characteristics, type D patients did not differ significantly
from non-type D patients.
Type D Personality in Relation to Anxiety and Depression
In univariate analyses, type D personality was significantly
associated with a history of anxiety (relative risk (RR)03.37)
and depressive disorder (RR03.57) but also with symptoms
of depression (RR04.02) and anxiety (RR02.53) prior to ICD
implantation. After correcting for the confounding factors:
age, gender, ICD indication, and etiology, type D personality
was associated with a history of depressive disorder (odds
ratio (OR) 6.2, p<0.001) and a history of anxiety disorder (OR
3.9, p00.004). Furthermore, type D personality was associ-
ated with symptoms of anxiety (OR 4.0, p<0.001) and depres-
sion (OR 5.9, p<0.001) prior to ICD implantation.
Associates of Health Status Prior to ICD Implantation
As shown in Table 2, type D personality was independently
associated with poorer health status in the domains vitality,
mental health, bodily pain, and general health. Anxiety
symptoms and NYHA functional class were associates of
health status, influencing all eight SF-36 domains. Other
independent associates of poor health status were depres-
sive symptoms (on three domains) and history of anxiety
disorder (on one domain). In none of the final adjusted
models effect modification was present by gender or ICD
indication.
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Discussion
A paucity of studies have examined the level of psycholog-
ical morbidity in ICD patients prior to implantation, which
might potentially be an important determinant of psycho-
logical adaptation problems post-implantation. To our
knowledge, no study has investigated the association
between history of anxiety and depressive disorders, as
assessed with a clinical diagnostic interview and patient-
reported health status at the time of implantation in ICD
patients. In the current cohort of ICD patients enrolled in the
TICS study, we found that patients with a type D personality
Table 1 Baseline characteristics for the total TICS cohort and stratified by Type D personality
Total
(N0278)
Type D
(N059)
Non-type D
(N0219)
RR or mean
difference
(95 % CI) P value
Gender Male 230 (83) 51 (86) 179 (82) 1
Female 48 (17) 8 (14) 40 (17) 0.74 (0.37; 1.50) 0.396
Age mean (SD) 62.6 (10.6) 60 (12.3) 63 (10.5) 2.99 (−0.35; 6.33) 0.079
Indication Primary 196 (71) 43 (73) 153 (70) 1
Secondary 82 (30) 16 (27) 66 (30) 0.90 (0.57; 1.43) 0.652
Comorbidity Diabetes 54 (19) 12 (20) 42 (19) 1.06 (0.60; 1.88) 0.841
COPD 32 (12) 7 (12) 25 (11) 1.04 (0.47; 2.28) 0.924
CVA 12 (4) 1 (2) 11 (5) 0.34 (0.04; 2.56) 0.368
TIA 7 (3) 2 (3) 5 (2) 1.48 (0.43; 7.46) 0.360
Etiology Ischemic 170 (61) 35 (60) 135 (62) 1
Non-ischemic 79 (28) 21 (36) 58 (27) 0.89 (0.71; 1.12) 0.292
Other 29 (10) 3 (5) 26 (12) 0.53 (0.41; 0.68) <0.001
Smoking 58 (21) 20 (34) 38 (17) 1.95 (1.24; 3.09) 0.005
Alcohol
(use ≥1 glass/week)
175 (74) 34 (68) 141 (74) 0.91 (0.74; 1.12) 0.319
LVEF, mean
(SD, N0262)
30 (15) 26 (14) 30 (15) −4.80 (−9.35; −0.24) 0.039
NYHA class I 36 (13) 6 (10) 30 (14) 1
II 165 (62) 33 (56) 135 (57) 0.85 (0.38; 1.89) 0.680
III 68 (25) 18 (31) 50 (23) 1.20 (0.90; 1.60) 0.259
Medication Beta-blocker 229 (82) 52 (88) 177 (81) 1.07 (1.097; 1.22) 0.211
Amiodarone 27 (10) 8 (14) 19 (9) 1.55 (0.72; 3.38) 0.266
Diuretics 184 (67) 44 (75) 140 (64) 1.16 (0.97; 1.39) 0.135
Aldosterone antagonist 90 (33) 28 (48) 62 (28) 1.67 (1.18; 2.35) 0.006
ACE-I/AT-II antagonist 216 (78) 44 (75) 172 (79) 0.95 (0.81; 1.12) 0.516
Depressive symptoms
(cutoff ≥8)
42 (16) 22 (39) 20 (10) 4.02 (2.36; 6.82) <0.001
Anxiety symptoms
(cutoff ≥8)
66 (24) 27 (47) 39 (19) 2.53 (1.70; 3.75) <0.001
History of depressive
disorder
53 (19) 26(44) 27 (12) 3.57 (2.27; 5.64) <0.001
History of anxiety disorder 21 (8) 10(17) 11 (5) 3.37 (1.51; 7.56) 0.002
Health status, mean (SD) Physical functioning 60 (28) 50 (28) 62 (28) −11.6 (−19.85; −3.39) 0.006
Social functioning 71 (29) 58 (30) 75 (27) −17.11 (−25.32; −8.87) <0.001
Role limitations (physical) 45 (45) 33 (42) 47 (45) −14.22 (−27.45; 0.99) 0.030
Role limitations (emotional) 67 (41) 48 (45) 72 (39) −24.18 (−37.48; −10.88) 0.001
Mental health 74 (19) 59 (21) 78 (17) −18.58 (−24.73; −12.44) <0.001
Vitality 57 (23) 43 (19) 60 (22) −16.87 (−23.36; −10.38) <0.001
Bodily pain 75 (27) 61 (30) 78 (26) −17.60 (−26.39; −8.81) <0.001
General health 52 (20) 39 (18) 55 (20) −15.31 (−21.12; −9.50) <0.001
Presented as n (%) unless otherwise indicated
RR relative risk, CI confidence interval, COPD chronic obstructive pulmonary disease, CVA cerebrovascular accident, TIA transient ischemic
attack, LVEF left ventricular ejection fraction, NYHA New York Heart Association functional class
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were more likely to have a previous anxiety or depressive
disorder and to experience higher levels of anxiety and
depressive symptoms prior to implantation. Patients with a
type D personality also reported poorer health status in
several domains of the SF-36 compared with non-type D
patients, although the associations between type D and
various domains of health status were also influenced by
anxiety symptoms, depressive symptoms, a previous anxiety
or depressive disorder, and NYHA functional class.
In a previous study in ICD patients, Sears et al. found that a
history of depressive disorder was a predictor of poor health
status at 8 and 14 months post-implatation [18]. In our study,
we found that a history of an anxiety disorder was only asso-
ciated with one of the eight health status domains of the SF-36
(i.e., bodily pain), while a history of a depressive disorder was
associated with none of the domains in adjusted analysis. The
association between bodily pain and history of anxiety disorder
was also found in other populations—for example in the eld-
erly [41] and in patients with chronic pain [42].
In the TICS cohort, we found that NYHA functional
class, anxiety symptoms, and type D personality were the
most important associates of poor health status, with the
strongest and most consistent association found between
anxiety symptoms and health status. Intuitively, we would
have expected that personality factors would exert a stronger
influence on health status as compared to anxiety, as anxiety
is a mood state that may fluctuate over time and situations,
whereas type D personality is a stable personality trait [43].
A possible explanation for this finding could be that the
questionnaires were administered just prior to implantation,
with anxiety representing preimplantation anxiety with
respect to the upcoming ICD implantation.
Our results confirm those of previous studies on type D
personality in ICD patients, showing that a subset of ICD
patients has a greater risk of experiencing anxiety and
depression symptoms, especially those with a type D per-
sonality [19, 44]. Previous research in cardiac patients,
including ICD patients, has also shown that the presence
of type D personality is not only associated with anxiety or
depression symptoms prior to ICD implantation but with
negative health outcomes, including mortality and morbidity
as well [16, 19]. In a cohort of cardiac surgery patients, it
was found that pre-surgery affective disorders, affective
phenotypes, and personality traits (i.e., negative affect) were
associated with post-cardiac surgery morbidity outcomes
[45]. Moreover, there are indications that the preimplanta-
tion psychological profile remains unchanged during 1 year
follow-up [46]. Therefore, the preimplantation psychologi-
cal profile (i.e., type D personality, history of depressive or
anxiety disorder, and preimplantation depressive or anxiety
symptoms) of the ICD patient seems to be a factor that
should be carefully monitored, since it appears to be asso-
ciated with an increased risk of worse prognosis and poorer
health status in the longer term [14, 15, 20, 44, 47].
Table 2 Associates of health status
Health status
domain
Constant Type Da
(P value)
Anxiety
symptomsb
(P value)
Depressive
symptomsc
(P value)
History of
anxiety disorderd
(P value)
History of
depressive disorderd
(P value)
NYHA class
(P value)
Social functioning 91.4 −7.0 (0.11) −17.4 (<0.001) −13.2 (0.010) −6.6 (0.30) −1.2 (0.80) −7.3 (0.019)
Vitality 70.3 −9.2 (0.007) −13.6 (<0.001) −4.7 (0.24) −0.2 (0.97) −2.6 (0.47) −12.8 (<0.001)
Mental health 84.4 −11.5 (<0.001) −17.9 (<0.001) −2.7 (0.39) −4.1 (0.29) −3.0 (0.29) −3.3 (0.082)
General health
perception
41.2 −6.2 (0.04) −7.7 (0.01) −9.6 (0.008) −2.7 (0.54) −4.9 (0.13) −8.0 (<0.001)
Role limitation
(emotional)
94.0 −10.2 (0.11) −24.3 (<0.001) −14.8 (0.04) −15.6 (0.09) −0.7 (0.92) −16.8 (<0.001)
Bodily pain 94.8 −10.1 (0.02) −10.8 (0.01) −8.5 (0.10) −16.5 (0.01) 0.0 (0.99) −6.6 (0.04)
Role limitation
(physical)
96.5 −1.7 (0.81) −19.2 (0.005) −13.5 (0.10) −2.9 (0.77) 5.5 (0.46) −29.8 (<0.001)
Physical
functioning
109.0 −4.3 (0.32) −9.1 (0.03) −8.6 (0.09) 1.8 (0.77) −7.0 (0.13) −16.3 (<0.001)
The negative coefficients represent the amount by which the health status values are lower for patients with either a type D personality, anxiety
symptoms, depressive symptoms, a history of anxiety or depressive disorder, and a lower NYHA functional class score, compared to patients
without these factors. For each health status domain, only the significant covariates are presented. All analyses were adjusted for age, gender, LVEF,
and ICD indication; these were not significantly related to any of the domains
NYHA class New York Heart Association functional class
a Type D caseness, as assessed with the Type D Scale (DS14)
b Symptoms of anxiety, as indicated by the Hospital Anxiety and Depression Scale (HADS)
c Symptoms of depression, as indicated by the HADS, depression component: depressive symptoms present
d History of anxiety or depressive disorder, as measured with the Mini International Neuropsychiatric Interview (MINI)
Int.J. Behav. Med.
Given the results of the current study, future studies
should include stable psychological factors, such as type D
personality, and a history of anxiety or depressive disorder,
as the premorbid psychological functioning of ICD patients
is likely to be an important predictor of psychological mor-
bidity post-implantation. In clinical practice, knowledge of
the patient’s premorbid psychological status may help health
care professionals in managing and caring for ICD patients
more optimally. These patients could be identified prior to
implantation using either the brief 14-item Type D scale—in
particular given that type D personality is also associated
with a history of both anxiety and depressive disorder—or a
more extensive diagnostic interview if a psychologist is
accessible via psychological services of the hospital or the
MINI as used in the current study.
This study has some limitations. First, anxiety and
depressive symptoms were determined by means of self-
report rather than a clinical diagnostic interview. A self-
report measure can be influenced by social desirability. We
countered this limitation by emphasizing confidentiality of
all responses. However, in the current study, we also had
information on past diagnoses of anxiety and depressive
disorder using a clinical diagnostic interview. Second, the
number of patients with type D personality was somewhat
lower than that found in previous studies [16, 19, 48]. This
could have led to a reduced chance to identify relevant
associations with type D personality. Nevertheless, we
found significant associations between type D personality
and distress symptoms and health status, which is concur-
rent with previous research on type D personality [19, 49].
Third, the number of participants in some subgroups was
quite small, as was the number of women in this study,
potentially limiting the statistical power. Fourth, we had no
information on baseline characteristics for patients who
refused to participate in the study. It is possible that their
demographic and clinical profile differed from that of the
study participants, possibly limiting the generalizability of
the findings to the total sample. Finally, we had no informa-
tion on the psychological status of patients who refused to
participate. These patients might be more distressed and
experience poorer health than patients included in analyses.
In conclusion, this study showed that prior to ICD
implantation, type D personality is independently associated
with anxiety and depressive symptoms. Also, we found that
type D personality is independently associated with a his-
tory of anxiety or depressive disorder in ICD patients.
Furthermore, we found that type D personality, anxiety
and depressive symptoms, and history of anxiety and
depressive disorders comprise vulnerability factors for expe-
riencing poor health status prior to ICD implantation. Future
results from the TICS cohort will be able to demonstrate
whether patients with a type D personality and a previous
anxiety or depressive disorder will continue to experience
more distress and report poorer health status than patients
without these psychological characteristics, once follow-up
data are available. Follow-up of the TICS study cohort will
show whether patients with these characteristics may be at
higher risk of morbidity and mortality, including ventricular
arrhythmias necessitating ICD therapy. If these findings are
confirmed, these patients should be carefully monitored,
since psychological functioning is also associated with
adverse health outcomes in ICD patients, including the
occurrence of potentially life-threatening ventricular
arrhythmias and mortality [7, 50].
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